SELLAS Life Sciences Group
Stock Forecast, Prediction & Price Target
SELLAS Life Sciences Group Financial Estimates
SELLAS Life Sciences Group Revenue Estimates
SELLAS Life Sciences Group EBITDA Estimates
SELLAS Life Sciences Group Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $7.6M N/A | $1M -86.84% | $0 -100% | Avg: $31.98M Low: $31.98M High: $31.98M avg. 0% | Avg: $16.42M Low: $16.42M High: $16.42M avg. -48.64% | Avg: $89.09M Low: $89.09M High: $89.09M avg. 442.46% | Avg: $155.68M Low: $155.68M High: $155.68M avg. 74.73% |
Net Income
% change YoY
| $-20.69M N/A | $-40.65M -96.39% | $-37.34M 8.14% | Avg: $-38.46M Low: $-20.27M High: $-13.88M avg. -3.01% | Avg: $-34.19M Low: $-20.83M High: $-8.61M avg. 11.10% | Avg: $1.94M Low: $1.94M High: $1.94M avg. 105.68% | Avg: $37.77M Low: $37.77M High: $37.77M avg. 1842.85% |
EBITDA
% change YoY
| $-29.64M N/A | $-42.28M -42.62% | $529K 101.25% | Avg: $-6.39M Low: $-6.39M High: $-6.39M avg. -1309.11% | Avg: $-3.28M Low: $-3.28M High: $-3.28M avg. 48.64% | Avg: $-17.81M Low: $-17.81M High: $-17.81M avg. -442.46% | Avg: $-31.13M Low: $-31.13M High: $-31.13M avg. -74.73% |
EPS
% change YoY
| -$1.34 N/A | -$2.1 -56.71% | -$1.34 36.19% | Avg: -$0.61 Low: -$0.73 High: -$0.5 avg. 54.47% | Avg: -$0.52 Low: -$0.75 High: -$0.31 avg. 14.75% | Avg: $0.07 Low: $0.07 High: $0.07 avg. 113.46% | Avg: $1.36 Low: $1.36 High: $1.36 avg. 1842.85% |
Operating Expenses
% change YoY
| $32.69M N/A | $42.85M 31.06% | $37.86M -11.62% | Avg: $135.11M Low: $135.11M High: $135.11M avg. 256.79% | Avg: $69.39M Low: $69.39M High: $69.39M avg. -48.64% | Avg: $376.41M Low: $376.41M High: $376.41M avg. 442.46% | Avg: $657.73M Low: $657.73M High: $657.73M avg. 74.73% |
FAQ
What is SELLAS Life Sciences Group stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 489.16% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -20.27M, average is -38.46M and high is -13.88M.
What is SELLAS Life Sciences Group stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 117.13% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $31.98M, average is $31.98M and high is $31.98M.
What is SELLAS Life Sciences Group stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 506.38% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$0.73, average is -$0.61 and high is $-0.5.